Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
infectious disease
Biotech
GSK to move vaccine R&D group from Maryland to Massachusetts
GSK's vaccine and infectious disease R&D teams are planning a move northeast to Massachusetts. There, they'll join other GSK teams in the Boston area.
Darren Incorvaia
Feb 12, 2025 11:27am
GSK drops 1 potential 'cure' for hep B, focuses on bepirovirsen
Feb 5, 2025 6:00am
Inflammatix collects FDA clearance for ER sepsis diagnostic test
Jan 21, 2025 11:30am
Lindus debuts 'all-in-one' service for infectious disease trials
Nov 19, 2024 4:30pm
J&J drops phase 2 dengue candidate in latest shift from vaccines
Oct 4, 2024 10:14am
Roche rolls out 12-virus diagnostic test in Europe
Sep 24, 2024 1:00pm